https://www.selleckchem.com/pr....oducts/suzetrigine.h
In addition, the present review provides directions for future research in this area. This study aimed to investigate the efficacy and safety of tocilizumab (TCZ) in severe and refractory parenchymal neuro-Behçet's syndrome (p-NBS). We retrospectively analyzed five patients with p-NBS treated with TCZ in our center between 2013 and 2020, and six cases from literature research with the index terms "neuro-Behçet's syndrome" and "tocilizumab" on PubMed NCBI. A total of 11 patients with p-NBS were enrolled (5 males, 6 females), with a m
Like
Comment
Share
